An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease
- 10 July 2009
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 18 (8) , 1147-1168
Abstract
Several epidemiological studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) may protect against Alzheimer's disease (AD), especially for patients carrying one or more ϵ4 allele of the apolipoprotein E. The biological mechanism of this protection is not completely understood and may involve inhibition of COX activity, inhibition of β-amyloid1-42 (Aβ42) production and aggregation, inhibition of β-secretase activity, activation of PPAR-γ or stimulation of neurotrophin synthesis. Unfortunately, long-term, placebo-controlled clinical trials with both non-selective and COX-2 selective NSAIDs in AD patients produced negative results. A secondary prevention study with rofecoxib in patients with mild cognitive impairment and a primary prevention study with naproxen and celecoxib in elderly subjects with a family history of AD were also negative. All these failures have diminished the hope that NSAIDs could be beneficial in the treatment of AD. It is hypothesized that the chronic us...Keywords
This publication has 110 references indexed in Scilit:
- CHF5074, a novel γ‐secretase modulator, attenuates brain β‐amyloid pathology and learning deficit in a mouse model of Alzheimer's diseaseBritish Journal of Pharmacology, 2009
- Cognitive and Cerebral Metabolic Effects of Celecoxib Versus Placebo in People With Age-Related Memory Loss: Randomized Controlled StudyThe American Journal of Geriatric Psychiatry, 2008
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway HypothesisNeuron, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Substrate-targeting γ-secretase modulatorsNature, 2008
- Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer miceBrain Research, 2008
- Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticityBrain, 2008
- Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloidNeuroscience, 2007
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Purification and Characterization of the Human γ-Secretase ComplexBiochemistry, 2004